Translational Development Acquisition Corp. (TDACU) Payables (2023 - 2026)
Translational Development Acquisition's (TDACU) quarterly Payables came in at $724323.0 in Q1 2026, up 221.24% YoY from $225477.0 in Q1 2025, and up 99.92% on a QoQ basis from $362311.0 in Q4 2025.
Translational Development Acquisition Corp. (TDACU) Payables (2023 - 2026) Analysis & Trends
Translational Development Acquisition (TDACU) has 4 years of Payables data on file, last reported at $724323.0 in Q1 2026.
- Quarterly Payables rose 221.24% year-over-year to $724323.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $724323.0 (up 221.24% YoY) and the FY2025 annual result came in at $362311.0, up 2138.01% from the prior year.
- Payables advanced to $724323.0 in Q1 2026, from $362311.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $724323.0 in Q1 2026 to a low of $16189.0 in Q4 2024.
- A 4-year average of $301579.3 and a median of $271083.0 in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables slumped 95.36% — and 2025, when it soared 2138.01%.
- Tracing TDACU's Payables over 4 years: stood at $348752.0 in 2023, then tumbled by 95.36% to $16189.0 in 2024, then soared by 2138.01% to $362311.0 in 2025, then surged by 99.92% to $724323.0 in 2026.
- The last three Payables figures came in at $724323.0 (Q1 2026), $362311.0 (Q4 2025), and $271083.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724,323.00 |
| Dec 31, 2025 | 362,311.00 |
| Sep 30, 2025 | 271,083.00 |
| Jun 30, 2025 | 162,920.00 |
| Mar 31, 2025 | 225,477.00 |
| Dec 31, 2024 | 16,189.00 |
| Dec 31, 2023 | 348,752.00 |